Diabetes insipidus classification: Difference between revisions

Jump to navigation Jump to search
 
(26 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Diabetes insipidus}}
{{Diabetes insipidus}}
{{CMG}}
{{CMG}}; {{AE}} {{DAMI}}
==Overview==
==Overview==
Diabetes Insipidus can be classified into central and nephrogenic diabetes insipidus based on the response of the body to administration of desmopressin (DDAVP). Diabetes insipidus can also be classified into 5 based on the complaint of hypotonic polyuria, polydipsia and nocturia. The 4 types include; Central DI, Nephrogenic DI, Psychogenic DI, Gestational DI.
[[Diabetes insipidus]] can be classified into three types: [[central diabetes insipidus|central]], [[nephrogenic diabetes insipidus|nephrogenic]], and [[psychogenic]] diabetes insipidus. Some rare forms of the disease include [[Gestational age|gestational]] [[diabetes insipidus]], which occurs only in [[pregnancy]], and  [[autoimmune]] diabetes insipidus, which is caused by an [[autoimmune]] reaction.


== Classification ==
==Classification==
===Central DI===
==='''[[Central diabetes insipidus|Central DI]]'''===
CDI is caused by the destruction or degeneration of neurons originating in the supraoptic and paraventricular nuclei. Central DI, results from damage to the [[pituitary gland]], which disrupts the normal storage and release of ADH. The most common cause of central diabetes insipidus (CDI), accounting for the vast majority of cases, are idiopathic diabetes insipidus (DI)<ref name="pmid6640507">{{cite journal| author=Kimmel DW, O'Neill BP| title=Systemic cancer presenting as diabetes insipidus. Clinical and radiographic features of 11 patients with a review of metastatic-induced diabetes insipidus. | journal=Cancer | year= 1983 | volume= 52 | issue= 12 | pages= 2355-8 | pmid=6640507 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6640507  }} </ref><ref name="pmid11018166">{{cite journal| author=Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, Zecca S et al.| title=Central diabetes insipidus in children and young adults. | journal=N Engl J Med | year= 2000 | volume= 343 | issue= 14 | pages= 998-1007 | pmid=11018166 | doi=10.1056/NEJM200010053431403 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11018166 }} </ref>. Others include<ref name="pmid11018166">{{cite journal| author=Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, Zecca S et al.| title=Central diabetes insipidus in children and young adults. | journal=N Engl J Med | year= 2000 | volume= 343 | issue= 14 | pages= 998-1007 | pmid=11018166 | doi=10.1056/NEJM200010053431403 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11018166  }} </ref>;
*[[CDI]] is caused by the destruction or degeneration of [[neurons]] originating in the [[Supraoptic nucleus|supraoptic]] and [[Paraventricular nucleus|paraventricular nuclei]], which disrupts the normal storage and release of [[ADH]].  
*Familial and congenital disease
*The most common cause of [[central diabetes insipidus]] ([[CDI]]) is [[idiopathic]] [[diabetes insipidus]] (DI), which accounts for the vast majority of cases of CDI.<ref name="pmid6640507">{{cite journal| author=Kimmel DW, O'Neill BP| title=Systemic cancer presenting as diabetes insipidus. Clinical and radiographic features of 11 patients with a review of metastatic-induced diabetes insipidus. | journal=Cancer | year= 1983 | volume= 52 | issue= 12 | pages= 2355-8 | pmid=6640507 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6640507  }} </ref><ref name="pmid11018166">{{cite journal| author=Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, Zecca S et al.| title=Central diabetes insipidus in children and young adults. | journal=N Engl J Med | year= 2000 | volume= 343 | issue= 14 | pages= 998-1007 | pmid=11018166 | doi=10.1056/NEJM200010053431403 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11018166  }} </ref>
**Familial CDI<ref name="pmid11427695">{{cite journal| author=Burbach JP, Luckman SM, Murphy D, Gainer H| title=Gene regulation in the magnocellular hypothalamo-neurohypophysial system. | journal=Physiol Rev | year= 2001 | volume= 81 | issue= 3 | pages= 1197-267 | pmid=11427695 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11427695  }} </ref>
**Wolfram syndrome also known as DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness)<ref name="pmid26025012">{{cite journal| author=Bischoff AN, Reiersen AM, Buttlaire A, Al-Lozi A, Doty T, Marshall BA et al.| title=Selective cognitive and psychiatric manifestations in Wolfram Syndrome. | journal=Orphanet J Rare Dis | year= 2015 | volume= 10 | issue=  | pages= 66 | pmid=26025012 | doi=10.1186/s13023-015-0282-1 | pmc=4450481 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26025012  }} </ref>
**Congenital hypopituitarism<ref name="pmid8157716">{{cite journal| author=Yagi H, Nagashima K, Miyake H, Tamai S, Onigata K, Yutani S et al.| title=Familial congenital hypopituitarism with central diabetes insipidus. | journal=J Clin Endocrinol Metab | year= 1994 | volume= 78 | issue= 4 | pages= 884-9 | pmid=8157716 | doi=10.1210/jcem.78.4.8157716 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8157716  }} </ref>
**Septo-optic dysplasia<ref name="pmid4191531">{{cite journal| author=Hoyt WF, Kaplan SL, Grumbach MM, Glaser JS| title=Septo-optic dysplasia and pituitary dwarfism. | journal=Lancet | year= 1970 | volume= 1 | issue= 7652 | pages= 893-4 | pmid=4191531 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4191531  }} </ref>
*Neurosurgery or trauma<ref name="pmid2492841">{{cite journal| author=Seckl J, Dunger D| title=Postoperative diabetes insipidus. | journal=BMJ | year= 1989 | volume= 298 | issue= 6665 | pages= 2-3 | pmid=2492841 | doi= | pmc=1835326 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2492841  }} </ref><ref name="pmid16235676">{{cite journal| author=Nemergut EC, Zuo Z, Jane JA, Laws ER| title=Predictors of diabetes insipidus after transsphenoidal surgery: a review of 881 patients. | journal=J Neurosurg | year= 2005 | volume= 103 | issue= 3 | pages= 448-54 | pmid=16235676 | doi=10.3171/jns.2005.103.3.0448 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16235676  }} </ref>
*Cancer<ref name="pmid6640507">{{cite journal| author=Kimmel DW, O'Neill BP| title=Systemic cancer presenting as diabetes insipidus. Clinical and radiographic features of 11 patients with a review of metastatic-induced diabetes insipidus. | journal=Cancer | year= 1983 | volume= 52 | issue= 12 | pages= 2355-8 | pmid=6640507 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6640507  }} </ref>
*Hypoxic encephalopathy
*Infiltrative disorders<ref name="pmid20434166">{{cite journal| author=Grois N, Fahrner B, Arceci RJ, Henter JI, McClain K, Lassmann H et al.| title=Central nervous system disease in Langerhans cell histiocytosis. | journal=J Pediatr | year= 2010 | volume= 156 | issue= 6 | pages= 873-81, 881.e1 | pmid=20434166 | doi=10.1016/j.jpeds.2010.03.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20434166  }} </ref><ref name="pmid2797079">{{cite journal| author=Dunger DB, Broadbent V, Yeoman E, Seckl JR, Lightman SL, Grant DB et al.| title=The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis. | journal=N Engl J Med | year= 1989 | volume= 321 | issue= 17 | pages= 1157-62 | pmid=2797079 | doi=10.1056/NEJM198910263211704 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2797079  }} </ref>
**Langerhans cell histiocytosis (LCH)
**eosinophilic granuloma
*Post-supraventricular tachycardia<ref name="pmid6434116">{{cite journal| author=Canepa-Anson R, Williams M, Marshall J, Mitsuoka T, Lightman S, Sutton R| title=Mechanism of polyuria and natriuresis in atrioventricular nodal tachycardia. | journal=Br Med J (Clin Res Ed) | year= 1984 | volume= 289 | issue= 6449 | pages= 866-8 | pmid=6434116 | doi= | pmc=1443391 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6434116  }} </ref>
*Anorexia nervosa<ref name="pmid6835335">{{cite journal| author=Gold PW, Kaye W, Robertson GL, Ebert M| title=Abnormalities in plasma and cerebrospinal-fluid arginine vasopressin in patients with anorexia nervosa. | journal=N Engl J Med | year= 1983 | volume= 308 | issue= 19 | pages= 1117-23 | pmid=6835335 | doi=10.1056/NEJM198305123081902 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6835335 }} </ref>


===Nephrogenic DI===
==='''[[Nephrogenic diabetes insipidus|Nephrogenic DI]]'''===
The most common causes of ADH resistance severe enough to produce polyuria are hereditary nephrogenic DI in children, and chronic lithium ingestion and hypercalcemia in adults. Acquired causes are often partially reversible with cessation of the offending drug or correction of hypercalcemia. Other causes include;
*The most common causes of [[ADH]] resistance severe enough to produce [[polyuria]] are hereditary nephrogenic DI (in children) and chronic [[lithium]] ingestion and [[hypercalcemia]] (in adults).  
*Hereditary Nephrogenic Diabetes Insipidus<ref name="pmid10477148">{{cite journal| author=van Lieburg AF, Knoers NV, Monnens LA| title=Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus. | journal=J Am Soc Nephrol | year= 1999 | volume= 10 | issue= 9 | pages= 1958-64 | pmid=10477148 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10477148  }} </ref>
*Acquired causes are often partially reversible with cessation of the offending drug or correction of [[hypercalcemia]].<ref name="pmid10477148">{{cite journal| author=van Lieburg AF, Knoers NV, Monnens LA| title=Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus. | journal=J Am Soc Nephrol | year= 1999 | volume= 10 | issue= 9 | pages= 1958-64 | pmid=10477148 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10477148  }} </ref><ref name="pmid15004257">{{cite journal| author=Sasaki S| title=Nephrogenic diabetes insipidus: update of genetic and clinical aspects. | journal=Nephrol Dial Transplant | year= 2004 | volume= 19 | issue= 6 | pages= 1351-3 | pmid=15004257 | doi=10.1093/ndt/gfh172 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15004257  }} </ref><ref name="pmid3037155">{{cite journal| author=Berl T| title=The cAMP system in vasopressin-sensitive nephron segments of the vitamin D-treated rat. | journal=Kidney Int | year= 1987 | volume= 31 | issue= 5 | pages= 1065-71 | pmid=3037155 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3037155  }} </ref>
**Vasopressin V2 receptor gene mutations<ref name="pmid15004257">{{cite journal| author=Sasaki S| title=Nephrogenic diabetes insipidus: update of genetic and clinical aspects. | journal=Nephrol Dial Transplant | year= 2004 | volume= 19 | issue= 6 | pages= 1351-3 | pmid=15004257 | doi=10.1093/ndt/gfh172 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15004257  }} </ref><ref name="pmid9329382">{{cite journal| author=Nomura Y, Onigata K, Nagashima T, Yutani S, Mochizuki H, Nagashima K et al.| title=Detection of skewed X-inactivation in two female carriers of vasopressin type 2 receptor gene mutation. | journal=J Clin Endocrinol Metab | year= 1997 | volume= 82 | issue= 10 | pages= 3434-7 | pmid=9329382 | doi=10.1210/jcem.82.10.4312 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9329382  }} </ref>
**Aquaporin-2 gene mutation<ref name="pmid15153548">{{cite journal| author=Devonald MA, Karet FE| title=Renal epithelial traffic jams and one-way streets. | journal=J Am Soc Nephrol | year= 2004 | volume= 15 | issue= 6 | pages= 1370-81 | pmid=15153548 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15153548  }} </ref>
*Lithium toxicity<ref name="pmid19384328">{{cite journal| author=Grünfeld JP, Rossier BC| title=Lithium nephrotoxicity revisited. | journal=Nat Rev Nephrol | year= 2009 | volume= 5 | issue= 5 | pages= 270-6 | pmid=19384328 | doi=10.1038/nrneph.2009.43 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19384328  }} </ref>
*Hypercalcemia<ref name="pmid3037155">{{cite journal| author=Berl T| title=The cAMP system in vasopressin-sensitive nephron segments of the vitamin D-treated rat. | journal=Kidney Int | year= 1987 | volume= 31 | issue= 5 | pages= 1065-71 | pmid=3037155 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3037155 }} </ref>
*Hypokalemia<ref name="pmid26674602">{{cite journal| author=Khositseth S, Uawithya P, Somparn P, Charngkaew K, Thippamom N, Hoffert JD et al.| title=Autophagic degradation of aquaporin-2 is an early event in hypokalemia-induced nephrogenic diabetes insipidus. | journal=Sci Rep | year= 2015 | volume= 5 | issue=  | pages= 18311 | pmid=26674602 | doi=10.1038/srep18311 | pmc=4682130 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26674602  }} </ref>, Persistent severe hypokalemia (plasma potassium concentration usually below 3 meq/L) can impair urinary concentrating ability
*Other — Nephrogenic DI has been described in a number of other clinical settings
**Renal disease
***Sickle cell disease or trait
***Autosomal dominant polycystic kidney disease
***Medullary cystic kidney disease
***Renal amyloidosis<ref name="pmid13807843">{{cite journal| author=CARONE FA, EPSTEIN FH| title=Nephrogenic diabetes insipidus caused by amyloid disease. Evidence in man of the role of the collecting ducts in concentrating urine. | journal=Am J Med | year= 1960 | volume= 29 | issue=  | pages= 539-44 | pmid=13807843 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13807843  }} </ref>
***Sjögren's syndrome<ref name="pmid14320699">{{cite journal| author=SHEARN MA, TU WH| title=NEPHROGENIC DIABETIC INSIPIDUS AND OTHER DEFECTS OF RENAL TUBULAR FUNCTION IN SJOERGREN'S SYNDROME. | journal=Am J Med | year= 1965 | volume= 39 | issue=  | pages= 312-8 | pmid=14320699 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14320699  }} </ref>
**Drugs<ref name="pmid15806465">{{cite journal| author=Garofeanu CG, Weir M, Rosas-Arellano MP, Henson G, Garg AX, Clark WF| title=Causes of reversible nephrogenic diabetes insipidus: a systematic review. | journal=Am J Kidney Dis | year= 2005 | volume= 45 | issue= 4 | pages= 626-37 | pmid=15806465 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15806465  }} </ref>
***Cidofovir
***Foscarnet
***Amphotericin B
***Demeclocycline
***Ifosfamide
***Ofloxacin
***Orlistat
***Didanosine
**Pregnancy<ref name="pmid15863571">{{cite journal| author=Brewster UC, Hayslett JP| title=Diabetes insipidus in the third trimester of pregnancy. | journal=Obstet Gynecol | year= 2005 | volume= 105 | issue= 5 Pt 2 | pages= 1173-6 | pmid=15863571 | doi=10.1097/01.AOG.0000161811.02155.68 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15863571  }} </ref>
**Bardet-Biedl syndrome<ref name="pmid8270381">{{cite journal| author=Anadoliiska A, Roussinov D| title=Clinical aspects of renal involvement in Bardet-Biedl syndrome. | journal=Int Urol Nephrol | year= 1993 | volume= 25 | issue= 5 | pages= 509-14 | pmid=8270381 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8270381  }} </ref>
**Bartter syndrome<ref name="pmid11893344">{{cite journal| author=Peters M, Jeck N, Reinalter S, Leonhardt A, Tönshoff B, Klaus G Gü et al.| title=Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. | journal=Am J Med | year= 2002 | volume= 112 | issue= 3 | pages= 183-90 | pmid=11893344 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11893344 }} </ref>


===Psychogenic DI===
==='''Psychogenic Diabetes Insipidus'''===
Psychogenic DI also known as dipsogenic DI or primary polydispsia is characterized by a primary increase in water intake. This disorder is most often seen middle-aged women and in patients with psychiatric illnesses, including those taking a phenothiazine which can lead to the sensation of a dry mouth. Primary polydipsia can also be induced by hypothalamic lesions that directly affect the thirst center, as may occur with an infiltrative disease such as sarcoidosisis
*This type of [[DI]] is characterized primarily by excessive water intake. This disorder is most often observed among young women and mentally unstable patients with [[Psychiatric illness|psychiatric illnesses]], including those taking a [[phenothiazine]], which can lead to the sensation of a dry mouth.<ref name="pmid15153548">{{cite journal| author=Devonald MA, Karet FE| title=Renal epithelial traffic jams and one-way streets. | journal=J Am Soc Nephrol | year= 2004 | volume= 15 | issue= 6 | pages= 1370-81 | pmid=15153548 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15153548  }} </ref>
*Other identifiable causes of psychogenic diabetes insipidus include [[sarcoidosis]] and [[lesions]] to the [[Hypothalamic pituitary adrenal axis|hypothalamic pituitary axis]], which may disrupt the thirst center, thereby increasing the sensation of [[thirst]] and water consumption.<ref name="pmid9329382">{{cite journal| author=Nomura Y, Onigata K, Nagashima T, Yutani S, Mochizuki H, Nagashima K et al.| title=Detection of skewed X-inactivation in two female carriers of vasopressin type 2 receptor gene mutation. | journal=J Clin Endocrinol Metab | year= 1997 | volume= 82 | issue= 10 | pages= 3434-7 | pmid=9329382 | doi=10.1210/jcem.82.10.4312 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9329382  }} </ref>


===Gestational DI===
==='''Gestational Diabetes Insipidus'''===
Gestational diabetes insipidus is an uncommon clinical disease whose prevalence is approximately 2-3 per 100,000 pregnancies. It results when an enzyme made by the placenta destroys ADH in the mother. The placenta is the system of blood vessels and other tissue that develops with the fetus. The placenta allows exchange of nutrients and waste products between mother and fetus.Most cases of gestational DI can be treated with desmopressin. In rare cases, however, an abnormality in the thirst mechanism causes gestational DI, and desmopressin should not be used.
*This type of [[diabetes insipidus]] occurs only during [[pregnancy]]. Gestational DI occurs when an [[enzyme]] made by the [[placenta]] destroys [[ADH]] produced in the mother.  
*Most cases of gestational DI can be successfully treated with [[desmopressin]].<ref name="pmid15153548" />
*In rare cases, however, an abnormality in the thirst mechanism causes gestational DI, and [[desmopressin]] should not be used.<ref name="pmid19384328">{{cite journal| author=Grünfeld JP, Rossier BC| title=Lithium nephrotoxicity revisited. | journal=Nat Rev Nephrol | year= 2009 | volume= 5 | issue= 5 | pages= 270-6 | pmid=19384328 | doi=10.1038/nrneph.2009.43 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19384328  }} </ref>
 
==='''Autoimmune Diabetes Insipidus'''===
*This type of [[diabetes insipidus]] is very rare. It results from an [[autoimmune]] cause.<ref name="pmid9329382" />
*It is usually associated with other [[autoimmune]] diseases and typically affects women of childbearing age.<ref name="pmid9329382" />


==References==
==References==

Latest revision as of 19:36, 26 October 2017

Diabetes insipidus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Diabetes insipidus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT scan

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Diabetes insipidus classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Diabetes insipidus classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Diabetes insipidus classification

CDC on Diabetes insipidus classification

Diabetes insipidus classification in the news

Blogs on Diabetes insipidus classification

Directions to Hospitals Treating Diabetes insipidus

Risk calculators and risk factors for Diabetes insipidus classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]

Overview

Diabetes insipidus can be classified into three types: central, nephrogenic, and psychogenic diabetes insipidus. Some rare forms of the disease include gestational diabetes insipidus, which occurs only in pregnancy, and autoimmune diabetes insipidus, which is caused by an autoimmune reaction.

Classification

Central DI

Nephrogenic DI

  • The most common causes of ADH resistance severe enough to produce polyuria are hereditary nephrogenic DI (in children) and chronic lithium ingestion and hypercalcemia (in adults).
  • Acquired causes are often partially reversible with cessation of the offending drug or correction of hypercalcemia.[3][4][5]

Psychogenic Diabetes Insipidus

  • This type of DI is characterized primarily by excessive water intake. This disorder is most often observed among young women and mentally unstable patients with psychiatric illnesses, including those taking a phenothiazine, which can lead to the sensation of a dry mouth.[6]
  • Other identifiable causes of psychogenic diabetes insipidus include sarcoidosis and lesions to the hypothalamic pituitary axis, which may disrupt the thirst center, thereby increasing the sensation of thirst and water consumption.[7]

Gestational Diabetes Insipidus

Autoimmune Diabetes Insipidus

References

  1. Kimmel DW, O'Neill BP (1983). "Systemic cancer presenting as diabetes insipidus. Clinical and radiographic features of 11 patients with a review of metastatic-induced diabetes insipidus". Cancer. 52 (12): 2355–8. PMID 6640507.
  2. Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, Zecca S; et al. (2000). "Central diabetes insipidus in children and young adults". N Engl J Med. 343 (14): 998–1007. doi:10.1056/NEJM200010053431403. PMID 11018166.
  3. van Lieburg AF, Knoers NV, Monnens LA (1999). "Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus". J Am Soc Nephrol. 10 (9): 1958–64. PMID 10477148.
  4. Sasaki S (2004). "Nephrogenic diabetes insipidus: update of genetic and clinical aspects". Nephrol Dial Transplant. 19 (6): 1351–3. doi:10.1093/ndt/gfh172. PMID 15004257.
  5. Berl T (1987). "The cAMP system in vasopressin-sensitive nephron segments of the vitamin D-treated rat". Kidney Int. 31 (5): 1065–71. PMID 3037155.
  6. 6.0 6.1 Devonald MA, Karet FE (2004). "Renal epithelial traffic jams and one-way streets". J Am Soc Nephrol. 15 (6): 1370–81. PMID 15153548.
  7. 7.0 7.1 7.2 Nomura Y, Onigata K, Nagashima T, Yutani S, Mochizuki H, Nagashima K; et al. (1997). "Detection of skewed X-inactivation in two female carriers of vasopressin type 2 receptor gene mutation". J Clin Endocrinol Metab. 82 (10): 3434–7. doi:10.1210/jcem.82.10.4312. PMID 9329382.
  8. Grünfeld JP, Rossier BC (2009). "Lithium nephrotoxicity revisited". Nat Rev Nephrol. 5 (5): 270–6. doi:10.1038/nrneph.2009.43. PMID 19384328.


Template:WikiDoc Sources